|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
IMP |
|
RGD |
PMID:26077568 |
RGD:13800514 |
NCBI chr19:50,307,569...50,312,812
|
|
G |
Hsd11b2em1Jmul |
hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul |
|
IMP |
|
RGD |
PMID:26077568 |
RGD:13800514 |
|
|
|
G |
Lepr |
leptin receptor |
|
IMP |
|
RGD |
PMID:27465994 |
RGD:12911217 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Leprem2Mcwi |
leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:27465994 |
RGD:12911217 |
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Ahrem2Sage |
aryl hydrocarbon receptor; ZFN induced mutant2, Sage |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
|
|
|
G |
Fh |
fumarate hydratase |
|
IMP |
|
RGD |
PMID:27556703 |
RGD:13792708 |
NCBI chr13:90,056,565...90,082,450
|
|
G |
Fhem1 |
fumarate hydratase; TALEN induced mutant 1 |
|
IMP |
|
RGD |
PMID:27556703 |
RGD:13792708 |
|
|
G |
Ren |
renin |
exacerbates |
IMP |
compared to wild type |
RGD |
PMID:21242461 |
RGD:7771614 |
NCBI chr13:47,348,312...47,359,539
|
|
G |
Renem1Mcwi |
renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin |
exacerbates |
IMP |
compared to wild type |
RGD |
PMID:21242461 |
RGD:7771614 |
|
|
|
G |
Ctns |
cystinosin, lysosomal cystine transporter |
|
IMP |
|
RGD |
PMID:35695380 |
RGD:155630629 |
NCBI chr10:58,300,069...58,315,725
|
|
G |
Gla |
galactosidase, alpha |
|
IMP |
|
RGD |
PMID:29979634 |
RGD:401976416 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:29979634 |
RGD:401976416 |
|
|
|
G |
Add3 |
adducin 3 |
|
IMP |
|
RGD |
PMID:32029431 |
RGD:150340736 |
NCBI chr 1:262,152,722...262,260,504
|
|
G |
Col4a5 |
collagen type IV alpha 5 chain |
|
IMP |
|
RGD |
PMID:34675305 |
RGD:329845598 |
NCBI chr X:109,907,251...110,111,214
|
|
G |
Ctns |
cystinosin, lysosomal cystine transporter |
|
IMP |
|
RGD |
PMID:35695380 |
RGD:155630629 |
NCBI chr10:58,300,069...58,315,725
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
|
IMP |
|
RGD |
PMID:19155635 |
RGD:2316657 |
NCBI chr 1:164,764,119...164,779,578
|
|
|
G |
Atp7b |
ATPase copper transporting beta |
|
IAGP |
|
RGD |
PMID:11509115 |
RGD:1302456 |
NCBI chr16:76,654,725...76,726,092
|
|
G |
Atp7bhts |
ATPase copper transporting beta; hepatitis |
|
IAGP |
|
RGD |
PMID:11509115 |
RGD:1302456 |
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Ahrem2Sage |
aryl hydrocarbon receptor; ZFN induced mutant2, Sage |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
|
|
|
G |
Ctns |
cystinosin, lysosomal cystine transporter |
|
IMP |
|
RGD |
PMID:35695380 |
RGD:155630629 |
NCBI chr10:58,300,069...58,315,725
|
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
IMP |
associated Experimental Diabetes Mellitus, hypertension; compared to wild type SS |
RGD |
PMID:37643020 |
RGD:401827835 |
NCBI chr19:30,327,643...30,355,856
|
|
G |
Mmp2em2Mcwi |
matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
|
IMP |
associated Experimental Diabetes Mellitus, hypertension; compared to wild type SS |
RGD |
PMID:37643020 |
RGD:401827835 |
|
|
G |
Nppc |
natriuretic peptide C |
|
IMP |
compared to wild type |
RGD |
PMID:29566041 |
RGD:127284867 |
NCBI chr 9:94,767,986...94,772,186
|
|
G |
Nppcem3Kyo |
natriuretic peptide C; ZFN induced mutant 3, Kyo |
|
IMP |
compared to wild type |
RGD |
PMID:29566041 |
RGD:127284867 |
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Ahrem2Sage |
aryl hydrocarbon receptor; ZFN induced mutant2, Sage |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
|
|
|
G |
Lepr |
leptin receptor |
|
IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:10901178 |
RGD:401965414 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
IAGP |
|
RGD |
PMID:23569176 |
RGD:8657335 |
NCBI chr 4:26,312,403...26,488,456
|
|
G |
Anks6 |
ankyrin repeat and sterile alpha motif domain containing 6 |
|
IAGP |
|
RGD |
PMID:7933831 |
RGD:1300446 |
NCBI chr 5:66,104,770...66,146,186
|
|
G |
Anks6PKD |
ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease |
|
IAGP |
|
RGD |
PMID:7933831 |
RGD:1300446 |
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
|
TAS |
|
RGD |
PMID:12716758 |
RGD:1578327 |
NCBI chr 6:46,058,439...46,065,148
|
|
|
G |
Lepr |
leptin receptor |
|
IMP IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:26537785 PMID:30278832 |
RGD:12911216, RGD:401960095 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Leprem4Lizh |
leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh |
|
IMP |
|
RGD |
PMID:26537785 |
RGD:12911216 |
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
|
IMP |
|
RGD |
PMID:19155635 |
RGD:2316657 |
NCBI chr 1:164,764,119...164,779,578
|
|
|
G |
Ednra |
endothelin receptor type A |
|
IDA |
|
RGD |
PMID:16157796 |
RGD:1581830 |
NCBI chr19:47,137,360...47,207,961
|
|
G |
Lepr |
leptin receptor |
disease_progression |
IMP IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:27465994 PMID:28746409 |
RGD:12911217, RGD:401965413 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Leprem2Mcwi |
leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
disease_progression |
IMP |
|
RGD |
PMID:27465994 |
RGD:12911217 |
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
ameliorates |
IMP |
compared to wild type SS |
RGD |
PMID:37643020 |
RGD:401827835 |
NCBI chr19:30,327,643...30,355,856
|
|
G |
Mmp2em2Mcwi |
matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
ameliorates |
IMP |
compared to wild type SS |
RGD |
PMID:37643020 |
RGD:401827835 |
|
|
G |
Shc1 |
SHC adaptor protein 1 |
ameliorates |
IMP |
|
RGD |
PMID:27270176 |
RGD:12792230 |
NCBI chr 2:177,135,649...177,147,257
|
|
G |
Shc1em4Mcwi |
SHC adaptor protein 1; ZFN induced mutant 4, Medical College of Wisconsin |
ameliorates |
IMP |
|
RGD |
PMID:27270176 |
RGD:12792230 |
|
|
G |
Sod3 |
superoxide dismutase 3 |
onset |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:31972339 |
RGD:150573712 |
NCBI chr14:62,822,865...62,828,602
|
|
G |
Sod3m1Mcwi |
superoxide dismutase 3; mutation 1, Medical College of Wisconsin |
onset |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:31972339 |
RGD:150573712 |
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
induces |
IMP |
compared to wild type vehicle-treated control |
RGD |
PMID:29923767 |
RGD:149735534 |
NCBI chr 8:14,044,216...14,148,808
|
|
G |
Trpc6em1Mcwi |
transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin |
induces |
IMP |
compared to wild type vehicle-treated control |
RGD |
PMID:29923767 |
RGD:149735534 |
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Ahrem2Sage |
aryl hydrocarbon receptor; ZFN induced mutant2, Sage |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Ahrem2Sage |
aryl hydrocarbon receptor; ZFN induced mutant2, Sage |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
|
|
|
G |
Nek8 |
NIMA-related kinase 8 |
|
IAGP |
compared to control Lewis |
RGD |
PMID:22899815 |
RGD:40924667 |
NCBI chr10:63,558,940...63,570,954
|
|
G |
Nek8lpkArc |
NIMA-related kinase 8; lpk mutant, Arc |
|
IAGP |
compared to control Lewis |
RGD |
PMID:22899815 |
RGD:40924667 |
|
|
G |
Tmem67 |
transmembrane protein 67 |
|
IAGP |
|
RGD |
PMID:19515853 |
RGD:8554306 |
NCBI chr 5:30,333,793...30,386,702
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
sexual_dimorphism |
IMP |
females compared to Hsd:SD females |
RGD |
PMID:23859880 |
RGD:13204753 |
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Ahrem2Sage |
aryl hydrocarbon receptor; ZFN induced mutant2, Sage |
sexual_dimorphism |
IMP |
females compared to Hsd:SD females |
RGD |
PMID:23859880 |
RGD:13204753 |
|
|
G |
Anks6 |
ankyrin repeat and sterile alpha motif domain containing 6 |
|
IAGP |
compared to PKD |
RGD |
PMID:7933831 |
RGD:1300446 |
NCBI chr 5:66,104,770...66,146,186
|
|
G |
Anks6PKD |
ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease |
|
IAGP |
compared to PKD |
RGD |
PMID:7933831 |
RGD:1300446 |
|
|
G |
Ctns |
cystinosin, lysosomal cystine transporter |
|
IMP |
|
RGD |
PMID:35695380 |
RGD:155630629 |
NCBI chr10:58,300,069...58,315,725
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
IMP |
compared to wild type |
RGD |
PMID:26077568 |
RGD:13800514 |
NCBI chr19:50,307,569...50,312,812
|
|
G |
Hsd11b2em1Jmul |
hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul |
|
IMP |
compared to wild type |
RGD |
PMID:26077568 |
RGD:13800514 |
|
|
G |
Mc4r |
melanocortin 4 receptor |
|
IMP |
|
RGD |
PMID:24400148 |
RGD:13825242 |
NCBI chr18:62,689,798...62,691,685
|
|
G |
Mc4rm1Hubr |
melanocortin 4 receptor; ENU induced mutation 1, Hubr |
|
IMP |
|
RGD |
PMID:24400148 |
RGD:13825242 |
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
IMP |
compared to FHH |
RGD |
PMID:24722447 |
RGD:12910103 |
NCBI chr 7:132,368,399...132,389,300
|
|
G |
Nr4a1m1Mcwi |
nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin |
|
IMP |
compared to FHH |
RGD |
PMID:24722447 |
RGD:12910103 |
|
|
G |
Tmem67 |
transmembrane protein 67 |
|
IAGP |
|
RGD |
PMID:30705305 PMID:11095650 PMID:15052665 |
RGD:14995942, RGD:1300514, RGD:15014788 |
NCBI chr 5:30,333,793...30,386,702
|
|
G |
Tmem67wpk |
transmembrane protein 67; wpk mutant |
|
IAGP |
|
RGD |
PMID:30705305 PMID:15052665 |
RGD:14995942, RGD:15014788 |
|
|
|
G |
Col4a5 |
collagen type IV alpha 5 chain |
|
IMP |
|
RGD |
PMID:34675305 |
RGD:329845598 |
NCBI chr X:109,907,251...110,111,214
|
|
G |
Lepr |
leptin receptor |
|
IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:30278832 |
RGD:401960095 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
Ednra |
endothelin receptor type A |
|
IMP |
|
RGD |
PMID:12538737 |
RGD:1581844 |
NCBI chr19:47,137,360...47,207,961
|
|
G |
Ednrb |
endothelin receptor type B |
|
IMP |
|
RGD |
PMID:12538737 |
RGD:1581844 |
NCBI chr15:87,055,490...87,086,765
|
|
|
G |
Vdr |
vitamin D receptor |
|
IMP |
|
RGD |
PMID:32231239 |
RGD:32716373 |
NCBI chr 7:130,864,764...130,916,757
|
|
G |
Vdrem2Thka |
vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka |
|
IMP |
|
RGD |
PMID:32231239 |
RGD:32716373 |
|
|
|
G |
Mecp2 |
methyl CpG binding protein 2 |
|
IMP |
|
RGD |
PMID:27313794 |
RGD:11568037 |
NCBI chr X:156,932,481...156,995,981
|
|
G |
Mecp2em1Sage |
methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:27313794 |
RGD:11568037 |
|
|
|
G |
Lepr |
leptin receptor |
|
IMP |
|
RGD |
PMID:27465994 |
RGD:12911217 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Leprem2Mcwi |
leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:27465994 |
RGD:12911217 |
|
|
|
G |
Add3 |
adducin 3 |
|
IMP |
|
RGD |
PMID:32029431 |
RGD:150340736 |
NCBI chr 1:262,152,722...262,260,504
|
|
G |
Lepr |
leptin receptor |
|
IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:30278832 PMID:10901178 PMID:28746409 |
RGD:401960095, RGD:401965414, RGD:401965413 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Sod3 |
superoxide dismutase 3 |
onset |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:31972339 |
RGD:150573712 |
NCBI chr14:62,822,865...62,828,602
|
|
G |
Sod3m1Mcwi |
superoxide dismutase 3; mutation 1, Medical College of Wisconsin |
onset |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:31972339 |
RGD:150573712 |
|
|
|
G |
Add3 |
adducin 3 |
|
IMP |
|
RGD |
PMID:32029431 |
RGD:150340736 |
NCBI chr 1:262,152,722...262,260,504
|
|
G |
Egfr |
epidermal growth factor receptor |
|
IDA |
|
RGD |
PMID:15033924 |
RGD:1581909 |
NCBI chr14:95,378,626...95,551,358
|
|
G |
Mir146b |
microRNA 146b |
sexual_dimorphism |
IMP |
|
RGD |
PMID:31668631 |
RGD:127285407 |
NCBI chr 1:245,203,438...245,203,525
|
|
G |
Mir146bem1Mcwi |
microRNA 146b; CRISPR/Cas9 induced mutant 1, Mcwi |
sexual_dimorphism |
IMP |
|
RGD |
PMID:31668631 |
RGD:127285407 |
|
|
G |
Sod3 |
superoxide dismutase 3 |
onset |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:31972339 |
RGD:150573712 |
NCBI chr14:62,822,865...62,828,602
|
|
G |
Sod3m1Mcwi |
superoxide dismutase 3; mutation 1, Medical College of Wisconsin |
onset |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:31972339 |
RGD:150573712 |
|
|
|
G |
Gla |
galactosidase, alpha |
onset |
IMP |
|
RGD |
PMID:29979634 |
RGD:401976416 |
NCBI chr X:102,062,497...102,073,915
|
|
G |
Glaem2Mcwi |
galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin |
onset |
IMP |
|
RGD |
PMID:29979634 |
RGD:401976416 |
|
|
|
G |
Col4a5 |
collagen type IV alpha 5 chain |
|
IMP |
|
RGD |
PMID:34675305 |
RGD:329845598 |
NCBI chr X:109,907,251...110,111,214
|
|
G |
Lepr |
leptin receptor |
treatment |
IAGP |
compared to ad lib fed rats; increased desmin, fibronectin and collagenase |
RGD |
PMID:11500530 |
RGD:628581 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Leprfa |
leptin receptor; fa mutant |
treatment |
IAGP |
compared to ad lib fed rats; increased desmin, fibronectin and collagenase |
RGD |
PMID:11500530 |
RGD:628581 |
|
|
G |
Sod3 |
superoxide dismutase 3 |
onset |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:31972339 |
RGD:150573712 |
NCBI chr14:62,822,865...62,828,602
|
|
G |
Sod3m1Mcwi |
superoxide dismutase 3; mutation 1, Medical College of Wisconsin |
onset |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:31972339 |
RGD:150573712 |
|
|
|
G |
Lepr |
leptin receptor |
|
IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:30278832 |
RGD:401960095 |
NCBI chr 5:121,409,735...121,593,201
|
|
|
G |
Ednra |
endothelin receptor type A |
|
IMP |
|
RGD |
PMID:12538737 |
RGD:1581844 |
NCBI chr19:47,137,360...47,207,961
|
|
G |
Ednrb |
endothelin receptor type B |
|
IMP |
|
RGD |
PMID:12538737 |
RGD:1581844 |
NCBI chr15:87,055,490...87,086,765
|
|
G |
Lepr |
leptin receptor |
disease_progression |
IMP IAGP |
compared to SS/JrHsdMcwi DNA:mutations:cds: : (rat) |
RGD |
PMID:27465994 PMID:10901178 PMID:30278832 |
RGD:12911217, RGD:401965414, RGD:401960095 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Leprem2Mcwi |
leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
disease_progression |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:27465994 |
RGD:12911217 |
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
ameliorates |
IMP |
compared to wild type SS |
RGD |
PMID:37643020 |
RGD:401827835 |
NCBI chr19:30,327,643...30,355,856
|
|
G |
Mmp2em2Mcwi |
matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
ameliorates |
IMP |
compared to wild type SS |
RGD |
PMID:37643020 |
RGD:401827835 |
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
IMP |
compared to FHH |
RGD |
PMID:24722447 |
RGD:12910103 |
NCBI chr 7:132,368,399...132,389,300
|
|
G |
Nr4a1m1Mcwi |
nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin |
|
IMP |
compared to FHH |
RGD |
PMID:24722447 |
RGD:12910103 |
|
|
G |
Sod3 |
superoxide dismutase 3 |
onset |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:31972339 |
RGD:150573712 |
NCBI chr14:62,822,865...62,828,602
|
|
G |
Sod3m1Mcwi |
superoxide dismutase 3; mutation 1, Medical College of Wisconsin |
onset |
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:31972339 |
RGD:150573712 |
|
|
|
G |
Ctns |
cystinosin, lysosomal cystine transporter |
|
IMP |
|
RGD |
PMID:35695380 |
RGD:155630629 |
NCBI chr10:58,300,069...58,315,725
|
|
G |
Lepr |
leptin receptor |
|
IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:10901178 |
RGD:401965414 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Mir542 |
microRNA 542 |
ameliorates |
IMP |
|
RGD |
PMID:32470449 |
RGD:401900731 |
NCBI chr X:137,722,176...137,722,254
|
|
|
G |
Edaradd |
EDAR associated via death domain |
|
IAGP |
DNA:missense mutation:exon:p.Pro153Ser(rat) |
RGD |
PMID:22013926 |
RGD:14398762 |
NCBI chr17:85,866,629...85,910,612
|
|
G |
EdaraddswhKyo |
EDAR-associated death domain;swh Kyo mutant |
|
IAGP |
DNA:missense mutation:exon:p.Pro153Ser(rat) |
RGD |
PMID:22013926 |
RGD:14398762 |
|
|